Ling Douglas S F, Benardo Larry S, Sacktor Todd C
Department of Physiology and Pharmacology, State University of New York Downstate Medical Center, Brooklyn, New York, 11203, USA.
Hippocampus. 2006;16(5):443-52. doi: 10.1002/hipo.20171.
Protein kinase Mzeta (PKMzeta), a constitutively active, atypical PKC isoform, enhances synaptic strength during the maintenance of long-term potentiation (LTP). Here we examine the mechanism by which PKMzeta increases synaptic transmission. Postsynaptic perfusion of PKMzeta during whole-cell recordings of CA1 pyramidal cells strongly potentiated the amplitude of AMPA receptor (AMPAR)-mediated miniature EPSCs (mEPSCs). Nonstationary fluctuation analysis of events recorded before and after PKMzeta enhancement showed that the kinase doubled the number of functional postsynaptic AMPAR channels. After sustained potentiation, application of a PKMzeta inhibitor reversed the increase in functional channel number to basal levels, suggesting that persistent increase of PKMzeta is required to maintain the postsynaptic localization of a mobile subpopulation of receptors. The kinase did not affect other sites of LTP expression, including presynaptic transmitter release, silent synapse conversion, or AMPAR unit conductance. Thus PKMzeta functions specifically to establish and maintain long-term increases in active postsynaptic AMPAR number.
蛋白激酶Mζ(PKMzeta)是一种组成型激活的非典型蛋白激酶C亚型,在长期增强(LTP)维持过程中增强突触强度。在此,我们研究PKMzeta增加突触传递的机制。在对CA1锥体神经元进行全细胞记录时,向突触后灌注PKMzeta可显著增强α-氨基-3-羟基-5-甲基-4-异恶唑丙酸受体(AMPAR)介导的微小兴奋性突触后电流(mEPSCs)的幅度。对PKMzeta增强前后记录的事件进行非平稳波动分析表明,该激酶使功能性突触后AMPAR通道数量增加了一倍。在持续增强后,应用PKMzeta抑制剂可将功能性通道数量的增加逆转至基础水平,这表明需要持续增加PKMzeta才能维持受体可移动亚群在突触后的定位。该激酶不影响LTP表达的其他位点,包括突触前递质释放、沉默突触转换或AMPAR单位电导。因此,PKMzeta的功能是特异性地建立和维持活跃突触后AMPAR数量的长期增加。